Alzheimer’s disease
-
PublishedOctober 10, 2022
Walk to End Alzheimer’s returns to downtown Brunswick Oct. 15
The annual Midcoast Area Walk to End Alzheimer’s starts with registration at 9 a.m. Saturday at the Maine Street mall and gazebo, with a welcome ceremony at 10 a.m. and walk start at 10:30 a.m.
-
PublishedSeptember 28, 2022
Gov. Mills launches program to give grants up to $2,000 to family caregivers
The $5.1 million program is for family caregivers of patients with disabilities, such as Alzheimer's and dementia, who are being cared for at home.
-
PublishedSeptember 27, 2022
Experimental Alzheimer’s drug slows cognitive decline in trial, firms say
Makers of the drug have already applied to the Food and Drug Administration for accelerated approval for lecanemab, based on earlier-stage data.
-
PublishedAugust 2, 2022
Even simple exercise may help aging brain, study hints
Stretching and balancing moves can be as beneficial as an aerobic workout.
-
PublishedApril 16, 2022
Commentary: Medicare is cleaning up FDA’s mess on Biogen’s Alzheimer’s drug
By clarifying what evidence it needs before it will pay for medicines like Aduhelm, the agency paved the way for improved drug innovation.
-
PublishedApril 5, 2022
Cumberland woman running Boston Marathon for those with Alzheimer’s
Jackie Mundry's beloved grandmother was diagnosed with dementia and Mundry's marathon team is raising funds to benefit the national Alzheimer's Association.
-
PublishedNovember 19, 2021
Commentary: Focus on hearing aids, not a questionable Alzheimer’s drug
Alzheimer’s groups will help far more people by promoting hearing aids and a healthy lifestyle than by touting Aduhelm.
-
PublishedNovember 13, 2021
Commentary: The next hospital crisis is coming. Let’s hope the U.S. is prepared
Response teams that respect and protect patients and care providers are one essential solution for behavioral emergencies among people with dementia.
-
PublishedJuly 29, 2021
Research looks for possible COVID-19 link to later Alzheimer’s
Experts stress far more research is needed – and getting underway – to tell if COVID-19 might raise the risk of Alzheimer's or other brain problems later in life, or if people eventually recover from 'brain fog.'
-
PublishedJuly 13, 2021
Medicare evaluating coverage for $56,000 Alzheimer’s drug
Although pricey drugs are now fairly commonplace, the recent approval of Aduhelm prompted an unusually intense backlash.